Bioscience Equity Partners: Detailed Company Information & Corporate Profile
Summary
Bioscience Equity Partners, founded in 2022, is headquartered in Meydan, Dubai, AE.
The firm specializes in capital market advisory, mergers and acquisitions, investment banking, initial public offerings, private equity, venture capital, biotechnology, medical technology, equity‑debt‑hybrid financing, and capital raising. Its focus spans both emerging biotechnologies and established medical technologies, positioning it to support companies through various funding stages.
By blending equity, debt, and hybrid structures, the firm tailors capital solutions to client needs. Operating with a lean team of 10–50 professionals led by Chief Executive Officer George Syrmalis MD PhD FRSM and Chief Operating Officer Daniella Mikic.
| Industries | |
| Bioscience Equity Partners Headquarters Address | Meydan Road Nad Al Sheba, Dubai, AE |
| Company Size | 10-50 employees |
| Specialities & Services | Capital Market Advisory, Mergers and Acquisitions, Investment Banking, Initial Public Offerings, Private Equity, Venture Capital, Biotechnology, Medical Technology, Equity-Debt-Hybrid Financing, Capital Raising |
| Founded | 2022 |
| Updated: | 2026-10-24 |
Workforce Turnover
Length of Employment
Bioscience Equity Partners's workforce includes employees across a wide range of tenure levels.
50% have been with the company for 3 to 4 years50% have been with the company for 8 to 10 years
Companies Similar to Bioscience Equity Partners
Bioscience Equity Partners Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
